These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 30144053)
1. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation. Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway. Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830 [TBL] [Abstract][Full Text] [Related]
4. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway. Kong JC; Miao WQ; Wang Y; Zhou SF Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-448 overexpression inhibits fibroblast proliferation and collagen synthesis and promotes cell apoptosis via targeting ABCC3 through the JNK signaling pathway. Xu F; Xu F; Xie S; Zuo W; Wen G; Zhao T; Wan X J Cell Physiol; 2020 Feb; 235(2):1374-1385. PubMed ID: 31506947 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140. Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156 [TBL] [Abstract][Full Text] [Related]
7. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II. Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417 [TBL] [Abstract][Full Text] [Related]
8. MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-β/p38/ATF1 signaling pathway. Wei YQ; Guo YF; Yang SM; Ma HH; Li J Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6252-6261. PubMed ID: 32572892 [TBL] [Abstract][Full Text] [Related]
9. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation. Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409 [TBL] [Abstract][Full Text] [Related]
10. ANO1 inhibits cardiac fibrosis after myocardial infraction via TGF-β/smad3 pathway. Gao Y; Zhang YM; Qian LJ; Chu M; Hong J; Xu D Sci Rep; 2017 May; 7(1):2355. PubMed ID: 28539652 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis. Chen L; Yang Y; Peng X; Yan H; Zhang X; Yin L; Yu H Aging (Albany NY); 2020 May; 12(9):8339-8351. PubMed ID: 32396525 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways. Guo X; Sunil C; Adeyanju O; Parker A; Huang S; Ikebe M; Tucker TA; Idell S; Qian G Sci Rep; 2022 Feb; 12(1):3053. PubMed ID: 35197539 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-33a deficiency inhibits proliferation and fibrosis through inactivation of TGF-β/Smad pathway in human cardiac fibroblasts. Yu B; Li W; Al F; Chen Z Pharmazie; 2017 Aug; 72(8):456-460. PubMed ID: 29441904 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction. Zhou Y; Shiok TC; Richards AM; Wang P J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527 [TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis. Huang C; Liang Y; Zeng X; Yang X; Xu D; Gou X; Sathiaseelan R; Senavirathna LK; Wang P; Liu L Am J Respir Cell Mol Biol; 2020 Apr; 62(4):440-453. PubMed ID: 31697569 [TBL] [Abstract][Full Text] [Related]
16. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast. Ba YD; Sun JH; Zhao XX Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239 [TBL] [Abstract][Full Text] [Related]
17. LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a. Sun J; Su W; Zhao X; Shan T; Jin T; Guo Y; Li C; Li R; Zhou Y; Shan H; Sun X; Liang H Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273058 [TBL] [Abstract][Full Text] [Related]
18. LINC01116 regulates proliferation, migration, and apoptosis of keloid fibroblasts by the TGF-β1/SMAD3 signaling via targeting miR-3141. Wu D; Zhou J; Tan M; Zhou Y Anal Biochem; 2021 Aug; 627():114249. PubMed ID: 34048784 [TBL] [Abstract][Full Text] [Related]
19. C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1. Qin H; Tang Y; Mao Y; Zhou X; Xu T; Liu W; Su X Cell Signal; 2022 May; 93():110274. PubMed ID: 35122989 [TBL] [Abstract][Full Text] [Related]
20. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]